acetylsalicylic acid
PL-ASA-002
Phase 2 small_molecule completed
Quick answer
acetylsalicylic acid for Upper Gastrointestinal Mucosal Damage is a Phase 2 program (small_molecule) at Protalix BioTherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Protalix BioTherapeutics
- Indication
- Upper Gastrointestinal Mucosal Damage
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed